Tennessee hospital using AI-assisted device for polyp detection in clinical trial

Listen
Text
  • Small
  • Medium
  • Large

Chattanooga, Tenn.-based Erlanger Health System began a clinical trial to test an artificial intelligence device used to increase polyp detection during colonoscopy, thechattanoogan.com reported Feb. 8.

The health system is using a device by Magentiq Eye that uses AI software during a screening colonoscopy to identify polyps. The device is designed to complement the polyp-identification efforts of the endoscopist.

The AI software was taught to detect abnormalities after being shown thousands of images with various stages of polyp development.

Arslan Kahloon, MD, chief of gastroenterology at Erlanger, said, "We think cancers that happen between colonoscopies are due to missed polyps hiding behind the folds or flat and difficult to find polyps, so if we can find these polyps with any kind of extra detection system then we can deal with them accordingly."

The trial is currently recruiting patients.

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast